Skip to main content
Top
Published in: Intensive Care Medicine 2/2005

01-02-2005 | Clinical Commentary

Why are physicians so skeptical about positive randomized controlled clinical trials in critical care medicine?

Authors: Jesús Villar, Lina Pérez-Méndez, Armando Aguirre-Jaime, Robert M. Kacmarek

Published in: Intensive Care Medicine | Issue 2/2005

Login to get access

Excerpt

Scientific evidence is an essential part of good medical practice. However, expert opinion, derived from personal experience and understanding of mechanisms, rather than scientific evidence is commonly used as a foundation for many decisions in medicine [2]. Practicing evidence-based critical care medicine is a difficult task; it must take into consideration the effectiveness of specific treatments in the context of patients who have multiple problems, and who are often receiving many different therapies in a setting that is different from those tested in most clinical trials. Although much of our care is based on expert opinion, results from many randomized clinical trials (RCT) have changed the practice of most critical care physicians. RCTs, when designed and performed appropriately, should provide the most reliable evidence of treatment effectiveness, particularly when the effects are small or moderate. Without clinical trials critical care physicians could continue applying ineffective and even harmful therapeutic interventions [3]. Recent RCTs enrolling large numbers of patients in the field of critical care medicine [4, 5, 6, 7] have reported harmful outcomes for well known treatments and beneficial effects of novel therapies. However, many clinicians do not translate the results of RCTs into clinical practice [8]. Several obstacles experienced by physicians can create barriers to the acceptance of RCTs [9]: lack of access to relevant information, lack of resources at the institutional level, lack of specialized training, incorrect interpretation or application of the evidence, rejection of evidence, influence of the clinical behavior at their institution, low salary, lack of financial incentives, reluctance to develop practice guidelines, and concern over increasing cost. …
Literature
1.
go back to reference Brochard L, Mancebo J, Tobin M (2003) Searching for evidence: don’t forget the foundations. Intensive Care Med 29:2109–1111CrossRefPubMed Brochard L, Mancebo J, Tobin M (2003) Searching for evidence: don’t forget the foundations. Intensive Care Med 29:2109–1111CrossRefPubMed
2.
go back to reference Buckley NA, Smith AJ (1996) Evidence-based medicine in toxicology: where is the evidence? Lancet 347:1167–1169CrossRefPubMed Buckley NA, Smith AJ (1996) Evidence-based medicine in toxicology: where is the evidence? Lancet 347:1167–1169CrossRefPubMed
3.
go back to reference Simes RJ (2002) Clinical trials and “real-world” medicine. Med J Aust 177:407–408PubMed Simes RJ (2002) Clinical trials and “real-world” medicine. Med J Aust 177:407–408PubMed
4.
go back to reference Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRefPubMed Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRefPubMed
5.
go back to reference Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, López-Rodríguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fischer CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709CrossRefPubMed Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, López-Rodríguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fischer CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709CrossRefPubMed
6.
go back to reference Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417CrossRefPubMed Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417CrossRefPubMed
7.
go back to reference Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMed Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMed
8.
go back to reference Rubenfeld GD, Cooper C, Carter G, Thompson BT, Hudson LD (2004) Barriers to providing lung-protective ventilation to patients with acute lung injury. Crit Care Med 32:1289–1293CrossRefPubMed Rubenfeld GD, Cooper C, Carter G, Thompson BT, Hudson LD (2004) Barriers to providing lung-protective ventilation to patients with acute lung injury. Crit Care Med 32:1289–1293CrossRefPubMed
9.
go back to reference Kalassian KG, Dremsizov T, Angus DC (2002) Translating research evidence into clinical practice: new challenges for critical care. Crit Care 6:11–14CrossRefPubMed Kalassian KG, Dremsizov T, Angus DC (2002) Translating research evidence into clinical practice: new challenges for critical care. Crit Care 6:11–14CrossRefPubMed
10.
go back to reference Taubes G (1996) Looking for the evidence in medicine. Science 272:22–24PubMed Taubes G (1996) Looking for the evidence in medicine. Science 272:22–24PubMed
11.
go back to reference Davis D, O’Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A (1999) Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behaviour or health care outcomes? JAMA 282:867–874CrossRefPubMed Davis D, O’Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A (1999) Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behaviour or health care outcomes? JAMA 282:867–874CrossRefPubMed
12.
go back to reference Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet I:1311–1315CrossRef Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet I:1311–1315CrossRef
13.
go back to reference Weinert CR, Gross CR, Marinelli WA (2003) Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals. Am J Respir Crit Care Med 167:1304–1309CrossRefPubMed Weinert CR, Gross CR, Marinelli WA (2003) Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals. Am J Respir Crit Care Med 167:1304–1309CrossRefPubMed
14.
go back to reference Villar J, Kacmarek RM, Hedenstierna G (2004) From ventilator-induced lung injury to physician-induced lung injury: why the reluctance to use small tidal volumes? Acta Anaesthesiol Scand 48:267–271CrossRefPubMed Villar J, Kacmarek RM, Hedenstierna G (2004) From ventilator-induced lung injury to physician-induced lung injury: why the reluctance to use small tidal volumes? Acta Anaesthesiol Scand 48:267–271CrossRefPubMed
15.
go back to reference Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166:1510–1514CrossRefPubMed Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166:1510–1514CrossRefPubMed
16.
go back to reference Steinbrook R (2003) How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome. N Engl J Med 348:1393–1401CrossRefPubMed Steinbrook R (2003) How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome. N Engl J Med 348:1393–1401CrossRefPubMed
17.
go back to reference Thompson B, Hayden D, Matthay MA, Brower R, Parson P (2001) Clinicians’ approach to mechanical ventilation in acute lung injury and ARDS. Chest 120:1622–1627CrossRefPubMed Thompson B, Hayden D, Matthay MA, Brower R, Parson P (2001) Clinicians’ approach to mechanical ventilation in acute lung injury and ARDS. Chest 120:1622–1627CrossRefPubMed
18.
go back to reference Hayden D, Schoenfeld D, Bernard G, Brower R (2000) Outcome of participants vs. eligible participants in clinical trial of critically ill patients (abstract). Am J Respir Crit Care Med 161:A210 Hayden D, Schoenfeld D, Bernard G, Brower R (2000) Outcome of participants vs. eligible participants in clinical trial of critically ill patients (abstract). Am J Respir Crit Care Med 161:A210
19.
go back to reference Villar J, Pérez-Méndez L, Kacmarek RM (1999) Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome. Intensive Care Med 25:930–935CrossRefPubMed Villar J, Pérez-Méndez L, Kacmarek RM (1999) Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome. Intensive Care Med 25:930–935CrossRefPubMed
20.
go back to reference Ferguson ND, Kacmarek RM, Chiche JD, Singh JM, Hallett DC, Mehta S, Stewart TE (2004) Screening of ARDS patients using standardized ventilator settings: influence on enrolment in a clinical trial. Intensive Care Med 30:1111–1116CrossRefPubMed Ferguson ND, Kacmarek RM, Chiche JD, Singh JM, Hallett DC, Mehta S, Stewart TE (2004) Screening of ARDS patients using standardized ventilator settings: influence on enrolment in a clinical trial. Intensive Care Med 30:1111–1116CrossRefPubMed
21.
go back to reference Freeman BD, Danner RL, Banks SM, Natanson C (2001) Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 164:190–192PubMed Freeman BD, Danner RL, Banks SM, Natanson C (2001) Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 164:190–192PubMed
22.
go back to reference Horrobin DF (2003) Are large clinical trials in rapidly lethal diseases usually unethical? Lancet 361:695–697CrossRefPubMed Horrobin DF (2003) Are large clinical trials in rapidly lethal diseases usually unethical? Lancet 361:695–697CrossRefPubMed
23.
go back to reference Petrucci N (2003) Generalisability of randomised controlled trials: a matter of discussion. Intensive Care Med 29:858PubMed Petrucci N (2003) Generalisability of randomised controlled trials: a matter of discussion. Intensive Care Med 29:858PubMed
24.
go back to reference Pronovost PJ, Berenholtz SM, Dorman T, Merritt WT, Martinez EA, Guyatt GH (2001) Evidence-based medicine in anesthesiology. Anesth Analg 92:787–794PubMed Pronovost PJ, Berenholtz SM, Dorman T, Merritt WT, Martinez EA, Guyatt GH (2001) Evidence-based medicine in anesthesiology. Anesth Analg 92:787–794PubMed
25.
go back to reference MRC Streptomycin in Tuberculosis Trials Committee (1948) Streptomycin treatment of pulmonary tuberculosis. BMJ II:769–783 MRC Streptomycin in Tuberculosis Trials Committee (1948) Streptomycin treatment of pulmonary tuberculosis. BMJ II:769–783
26.
go back to reference Hart PD (1999) A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s. BMJ 319:572–573PubMed Hart PD (1999) A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s. BMJ 319:572–573PubMed
27.
go back to reference Altman DG (1998) Confidence intervals for the number needed to treat. BMJ 317:1309–1312PubMed Altman DG (1998) Confidence intervals for the number needed to treat. BMJ 317:1309–1312PubMed
28.
go back to reference Roupie E, Lepage E, Wysocki M, Fagon JY, Chastre J, Dreyfuss D, Mentec H, Carlet J, Brun-Buisson C, Lemaire F, Brochard L (1999) Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. Intensive Care Med 25:920–929CrossRefPubMed Roupie E, Lepage E, Wysocki M, Fagon JY, Chastre J, Dreyfuss D, Mentec H, Carlet J, Brun-Buisson C, Lemaire F, Brochard L (1999) Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. Intensive Care Med 25:920–929CrossRefPubMed
29.
go back to reference Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30:51–61CrossRefPubMed Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30:51–61CrossRefPubMed
30.
go back to reference Hebert PC, Wells G, Martin C, Tweeddale M, Marshall J, Blajchman M, Pagliarello G, Sandham D, Schweitzer II, Boisvert D, Calder L (1999) Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study. Crit Care 3:57–63CrossRefPubMed Hebert PC, Wells G, Martin C, Tweeddale M, Marshall J, Blajchman M, Pagliarello G, Sandham D, Schweitzer II, Boisvert D, Calder L (1999) Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study. Crit Care 3:57–63CrossRefPubMed
31.
go back to reference Boraless H, Rao MP, Morgan C, Soni N, Goldhill DR, Brett SJ, Boralessi H, Contreras M (2002) A survey of physicians’ attitudes to transfusion practice in critically ill patients in the UK. Anaesthesia 57:584–588CrossRefPubMed Boraless H, Rao MP, Morgan C, Soni N, Goldhill DR, Brett SJ, Boralessi H, Contreras M (2002) A survey of physicians’ attitudes to transfusion practice in critically ill patients in the UK. Anaesthesia 57:584–588CrossRefPubMed
32.
go back to reference Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150CrossRefPubMed Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150CrossRefPubMed
33.
go back to reference Warren HS, Suffredini AF, Eichacker PQ, Munford RS (2002) Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med 347:1027–1030CrossRefPubMed Warren HS, Suffredini AF, Eichacker PQ, Munford RS (2002) Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med 347:1027–1030CrossRefPubMed
34.
go back to reference Ross SS (2004) From p values to Bayesian statistics, it’s all in the numbers. Scientist 18:24–25 Ross SS (2004) From p values to Bayesian statistics, it’s all in the numbers. Scientist 18:24–25
35.
go back to reference Heyland DK, MacDonald S, Keefe L, Drover JW (1998) Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 280:2013–2019CrossRefPubMed Heyland DK, MacDonald S, Keefe L, Drover JW (1998) Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 280:2013–2019CrossRefPubMed
36.
go back to reference Sadowski ZP, Alexander JH, Skrabucha B, Dyduszynski A, Kuch J, Nartowicz E, Swiatecka G, Kong DF, Granger CB (1999) Multicenter randomized trial and systematic overview of lidocaine in acute myocardial infarction. Am Heart J 137:792–798PubMed Sadowski ZP, Alexander JH, Skrabucha B, Dyduszynski A, Kuch J, Nartowicz E, Swiatecka G, Kong DF, Granger CB (1999) Multicenter randomized trial and systematic overview of lidocaine in acute myocardial infarction. Am Heart J 137:792–798PubMed
37.
go back to reference Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systemic review. BMJ 326:1167–1170CrossRefPubMed Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systemic review. BMJ 326:1167–1170CrossRefPubMed
38.
go back to reference Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421–1428PubMed Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421–1428PubMed
39.
go back to reference Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES (1998) Variation in carotid endarterectomy mortality in the Medicare population. JAMA 279:1278–1281CrossRefPubMed Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES (1998) Variation in carotid endarterectomy mortality in the Medicare population. JAMA 279:1278–1281CrossRefPubMed
40.
Metadata
Title
Why are physicians so skeptical about positive randomized controlled clinical trials in critical care medicine?
Authors
Jesús Villar
Lina Pérez-Méndez
Armando Aguirre-Jaime
Robert M. Kacmarek
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 2/2005
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-004-2519-7

Other articles of this Issue 2/2005

Intensive Care Medicine 2/2005 Go to the issue